Published in the Pediatric Infectious Disease Journal, this CITF-funded study led by Dr. Marc-André Langlois, along with Malaa Bhatt, Roger Zemek (University of Ottawa) found that approximately 1 in 8 individuals with COVID-19 did not develop antibodies detectable in blood serum (a process known as seroconversion) as a result of infection.